Lindsey T Maddox, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 Medical Center Dr, Clanton, AL 35045 Phone: 205-755-5933 |
Jennifer Merritt, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 Medical Center Dr, Clanton, AL 35045 Phone: 205-755-5933 Fax: 205-668-0894 |
Mrs. Sandy Bridgett Jensen, RN Registered Nurse - Psych/Mental Health, Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 11607 County Road 29, Clanton, AL 35045 Phone: 334-596-7957 |
News Archive
Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+™ delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).
A new survey of employer health benefits by the National Business Group on Health has found businesses expect their health care costs to jump 7 percent next year as they comply with new parts of the federal health care reform law. Employers also expect to increase workers' share of health care costs 5 percent, the study found.
That was the key question posed by Anita Bundy; Professor of Occupational Therapy at the University's the Faculty of Health Sciences, when she and her colleagues carried out an activity study of children aged five to seven at a Sydney primary school.
Researchers have identified mutation-defined subtypes of clear cell renal cell carcinoma that have distinct clinical outcomes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
› Verified 4 days ago